ArticleJournal of hematology & oncology2019

High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.

Wenwu Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.